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Abstract
Background: In order to assess the importance of environmental and genetic risk on transition from health to psychotic
disorder, a prospective study of individuals at average (n = 462) and high genetic risk (n = 810) was conducted.
Method: A three-year cohort study examined the rate of transition to psychotic disorder. Binary measures indexing
environmental exposure (combining urban birth, cannabis use, ethnicity and childhood trauma) and proxy genetic risk
(high-risk sibling status) were used to model transition.
Results: The majority of high-risk siblings (68%) and healthy comparison subjects (60%) had been exposed to one or more
environmental risks. The risk of transition in siblings (n = 9, 1.1%) was higher than the risk in healthy comparison subjects
(n = 2, 0.4%; ORadj = 2.2,95%CI:5–10.3). All transitions (100%) were associated with environmental exposure, compared to
65% of non-transitions (p = 0.014), with the greatest effects for childhood trauma (ORadj = 34.4,95%CI:4.4–267.4), cannabis
use (OR= 4.1,95%CI:1.1, 15.4), minority ethnic group (OR= 3.8,95%CI:1.2,12.8) and urban birth (OR= 3.7,95%CI:0.9,15.4). The
proportion of transitions in the population attributable to environmental and genetic risk ranged from 28% for minority
ethnic group, 45% for urban birth, 57% for cannabis use, 86% for childhood trauma, and 50% for high-risk sibling status.
Nine out of 11 transitions (82%) were exposed to both genetic and environmental risk, compared to only 43% of non-
transitions (p = 0.03).
Conclusion: Environmental risk associated with transition to psychotic disorder is semi-ubiquitous regardless of genetic
high risk status. Careful prospective documentation suggests most transitions can be attributed to powerful environmental
effects that become detectable when analysed against elevated background genetic risk, indicating gene-environment
interaction.
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Introduction
Several environmental factors have been implicated in the
aetiology of psychotic illness including urban birth and upbringing
[1], minority position [2], childhood trauma [3] and cannabis use
[4]. The impact of some environmental risk factors may be greater
in those at increased genetic risk suggesting possible interaction
between genetic and environmental risks [5].
Associations between environment and mental illness typically
are assessed in case-control studies that are easy to conduct but
prone to bias and confounding. Cohort studies following
individuals from health to illness transition are preferable but
expensive and impractical given long incubation periods between
exposure and outcome. In addition, given that the prevalence of
psychotic disorder in the general population is low [6], cohort
studies require large samples that, in order to reduce costs, are
subjected to inaccurate non-clinical diagnostic assessments. A
high-risk cohort study, following individuals with higher than
average genetic risk for psychotic disorder has advantages, given
that transition rates will be higher, thus reducing required length
of follow-up. In addition, by combining individuals of high average
risk in the cohort, a proxy variable indexing genetic risk is created
allowing for additional examination of genetic effects, as well as
gene-environment interaction [7]. There is also research on
transition in individuals described at ‘Ultra-High Risk’, however
transition in this population does not refer to transition from
health to psychotic disorder, as UHR samples in fact already are
help-seeking patients with mental disorder diagnoses [8] who
present for treatment at mental health services [9]. In the current
article, a detailed and careful follow-up was conducted of healthy
siblings (of patients with non-affective psychotic disorder) and
healthy comparison subjects sampled in the context of the
GROUP study [10], in order to determine true transitions from
(non-psychotic) health to psychotic disorder on the basis of clinical
interview, and determine the contribution of genetic and
environmental factors, taking into account the range of postnatal
risk factors for which meta-analytic evidence exists [5]. Given
these findings, we expect that urban birth, minority position,
childhood trauma and cannabis use all contribute to an increased
probability of transition to psychotic disorder, and that this impact




Full details of the GROUP study have been presented elsewhere
[10,11]. In representative geographical areas in the Netherlands
and Belgium, patients were identified through clinicians working
in regional psychotic disorder services, whose caseload was
screened for inclusion criteria. Subsequently, a group of patients
presenting at these services either as out-patients or in-patients
were recruited for the study. Healthy comparison subjects were
selected through random mailings to addresses in the catchment
areas of the cases. The GROUP study was not conducted in a
geographically well- defined small area, as it in fact included the
majority of mental health services in the Netherlands, and a
substantial part of mental health services in Dutch-speaking
Belgium. Healthy comparison subjects could not be representative
in all aspects, as an exclusion criterion was absence of a family
history of psychotic disorder. The goal was to collect a control
group that (i) was collected from the same geographical area as the
case in the relevant mental health service, (ii) was sufficiently large
to allow for chance variation and (iii) was frequency-matched in
age- and sex distribution to the siblings and (iv) had absence of
family history of psychotic disorder. Table 1 shows that healthy
comparison subjects and siblings had similar sex distribution and
also did not have large differences in age.
The full GROUP sample at baseline consisted of 1119 patients
with non-affective psychotic disorder, 1057 siblings of these
patients, 919 parents of the patients and 589 unrelated healthy
comparison subjects. Inclusion criteria were: (i) age range 16 to
50 years and (ii) good command of Dutch language. For patients,
an additional inclusion criterion was the presence of a clinical
diagnosis of non-affective psychotic disorder. Healthy comparison
subjects status was confirmed by using the Family Interview for
Genetic studies [12] with the control as informant, to establish
absence of first degree relatives with a psychotic disorder.
Diagnosis was based on the Diagnostic and Statistical Manual of
Mental Disorder-IV (DSM-IV) criteria [13], assessed with the
Comprehensive Assessment of Symptoms and History (CASH)
interview [14] or Schedules for Clinical Assessment for Neuro-
psychiatry (SCAN 2.1) [15]. The majority of patients had a DSM-
IV diagnosis of schizophrenia (DSM-IV 295.x; n= 940, 84%). In
the sibling and control groups, there were respectively 151 (14%)
and 60 participants (10%) with a history of a common mental
disorder at baseline, the majority of whom had a mood disorder
(DSM-IV 296.x). For the purpose of the current analysis, the
siblings and healthy comparison subjects groups were included.
The study was approved by the standing ethics committee
(Medisch Ethische Toetsingscommissie, UMC Utrecht), and all
the subjects gave written informed consent in accordance with the
committee’s guidelines. This committee waived the need for
additional informed consent of parents or supervisors for under-
aged participants ages 16 and older, given the non-experimental/
medical nature of this study.
Substance use
Substance use was assessed using the Composite International
Diagnostic Interview (CIDI) [16] and through urinalysis. Two
different measures of cannabis exposure, assessed both at baseline
and follow-up were used to construct incident exposure to
cannabis over the follow-up period: (i) CIDI lifetime cannabis
use (hereafter: interview cannabis use): none (0), versus any use (1) and
(ii) current cannabis use assessed by urinalysis (hereafter: urinalysis
cannabis use): none (0) and present (1). Urinalysis was carried out as
a screen for the presence of cannabis at the national Alcohol- and
Drug use ‘Jellinek’ Laboratory. The method used was immuno-
assays with a cut-off of 50 ng/ml. In addition, as an integrity
parameter, the creatinine level of every sample was measured.
Cannabis urine screening has a detection window up to 30 days,
but the detection time has been documented in literature to be
even longer (up to three months), depending on level of cannabis
use [17]. Given the relatively high cut-off level of 50 ng/ml, a
conservative detection window of one month can be inferred. A
dichotomous measure was created reflecting first exposure to
cannabis over the follow-up period, defined as any instance of
positive interview cannabis use or positive urinalysis cannabis use in those
without interview cannabis use and without urinalysis cannabis use at
baseline.
Childhood trauma
Childhood trauma was assessed with the Dutch version of the
Childhood Trauma Questionnaire (CTQ) 25 item Short Form
[18], consisting of 25 items rated on a 5-point Likert scale (1 =
never to 5 = very often). Emotional, physical and general abuse,
Transition from Health to Psychotic Disorder
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and emotional and physical neglect were assessed, five items
covering each trauma type [18]. Total trauma represents the mean
score of all 25 items (range in siblings and healthy comparison
subjects: 1–4.3). Conform previous analyses in this sample [19],
trauma scores were dichotomized a priori into high trauma and low
trauma, the cut-off being defined as the 80th percentile of scores
for the healthy comparison subjects.
Urban birth
Subjects were asked where they were born. To describe
urbanicity, a historical population density record was generated
for each municipality from 1930 onwards using the database of the
Central Bureau of Statistics (Netherlands) and the HISSTAT
database (University of Gent, Department Modern History,
Belgium). When data was not available, linear extrapolations
were computed. When historical names of municipalities disap-
peared from historical records (e.g. due to city mergers) available
date from the agglomerate city were used. For each location,
population density (by square kilometre, excluding water) at the
municipality for that year was computed, on the basis of which the
urbanicity code (1 =,500/km2; 2= 500–1000/km2; 3 = 1000–
1500/km2; 4= 1500–2500/km2; 5= 2500+/km2) was calculated.
In accordance with research using the five-level exposure, a binary
urban birth exposure was calculated combining categories 1 to 3
(‘‘0’’), reflecting low urbanicity, and 4 and 5 (‘‘1’’), reflecting high
urbanicity [20,21].
Psychosis measures
The Community Assessment of Psychic Experiences (CAPE;
www.cape42.homestead.com) was developed in order to rate self-
reports of lifetime psychotic experiences. Items are modelled on
patient experiences as contained in the PSE-9 [22] and the
schedules assessing negative symptoms such as the Scale for the
Assessment of Negative Symptoms (SANS) [23] and the Subjective
Experience of Negative Symptoms (SENS) [24]. Items are scored
on a 4-point scale. In the current analyses, CAPE dimensions of
frequency of positive experiences (20 items) and negative
experiences (14 items) were included (measured at baseline and
3-year follow-up), representing the person’s perceived psychosis
load over the lifetime (at baseline) or in the past three years
(follow-up). A total score representing the mean of all items was
calculated for each dimension (CAPE positive: range in siblings
and comparison subjects: 0–2.5; CAPE negative: range 0–2.4).
Other measures
At baseline and at follow-up, the short form of the Wechsler
Adult Intelligence Scale (WAIS) – III was assessed for an
indication of intellectual functioning, and included the following
tests: ‘Block Design’, ‘Digit Symbol’, ‘Arithmetic’ and ‘Informa-
tion’ [25,26]. The WHOQOL-BREF [27] was used at baseline
and at follow-up to assess four domains of quality of life (1)
physical health, (2) mental health, (3) social relationships and (4)
environment. At baseline, the Premorbid Adjustment Scale (PAS)
[28] was administered. The PAS is a rating scale that includes
measures of social isolation, peer relationships, functioning
outside of the family, and school functioning at 3 age periods
(up to age 12 [4 items], 12–15 [5 items], 16–18 years [10 items]).
Validity, interrater reliability and internal consistency have been
found to be high [29,30]. An overall score based on the three age
periods was created with a sample range from 0 (healthiest
adjustment) to 5 (lowest adjustment).
Follow-up
Healthy comparison subjects and siblings were eligible for
follow-up. Of these, 78% (n= 1272) were assessed at 3-year follow-
up (healthy comparison subjects: 78%, n= 462; siblings: 77%,
n= 810). Measures of cannabis use at follow-up reflected use over
the interval between baseline and follow-up. Ratings of CASH,
SCAN, SIS-R and CAPE at follow-up reflected the period
between baseline and follow-up. Mean follow-up was 3.3 years
(SD =0.5).
Transition
Transition from health to psychotic disorder was defined as (i)
onset of non-affective psychotic disorder in individuals without
psychotic disorder (DSMIV 295, 297, 298) and without psychotic
affective disorder at baseline [n = 11; 7 with 295, 3 with 298, 1
with documented psychotic illness who refused follow-up], (ii)
onset of affective disorder or other non-psychotic disorder with
evidence of psychotic symptoms rated of at least ‘‘considerable’’ or
‘‘severe’’ quality (or equivalent) on the CASH, PANSS or SCAN
in individuals without baseline affective disorder or other non-
psychotic disorder and without evidence of psychotic symptoms
rated of at least ‘‘considerable’’ or ‘‘severe’’ quality at baseline
(n = 0). Individuals who refused to be seen at follow-up were
queried about mental health and contacts with mental health
services. Participating relatives of refusing participants also
provided information.
Table 1. Demographics of participants in the GROUP study.
Variable Siblings (n =1057) Healthy comparison subjects (n =589)
Mean (standard deviation) Mean (standard deviation) t value (p)
Age at T0 27.8 (8.3) 30.4 (10.6) 5.53 (,0.001)
Gender, male (%) 45.6 45.7 20.03 (0.511)
Education, Verhagea 5.1 (2.1) 5.4 (1.8) 3.26 (0,001)
WAIS-III Estimated IQ 103.0 (15.3) 109.9 (14.8) 8.73 (,0.001)
Ethnicity, Caucasian (%) 83.2 92.0 4.98 (,0.001)
Urbanicity at birthb 2.7 (1.7) 2.6 (1.7) 20.27 (0.790)
aEducation (Verhage): range 0 (no education), 3–5 (school diploma) to 8 (university degree).
bUrbanicity: 1 =,500/km2; 2 = 500–1000/km2; 3 = 1000–1500/km2; 4 = 1500–2500/km2; 5 = 2500+/km2.
doi:10.1371/journal.pone.0076690.t001
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Analysis
Analyses were conducted using Stata, version 12 [31]. Analyses
focused on the siblings (n = 1057 at baseline and n= 810 at follow-
up) and healthy comparison subjects (n = 589 at baseline, n= 462
at follow-up). The dependent variable in the analyses was
transition to psychotic disorder. Standard errors were corrected
for hierarchical clustering of the data at the level of the family
(clustering of siblings in the same family) or, when applicable, for
clustering at the two levels occasioned by clustering of individuals
in the same family and of repeated measures within the same
person, using the Stata routines of cluster, xtreg or xtmixed, as
appropriate.
Associations were expressed as the odds ratio from the logistic
regression model (dichotomous transition outcome) or the
regression coefficient (B) from multilevel random regression
models (continuous variables). All analyses were a priori adjusted
for age and sex. Comparisons between transition and non-
transition status were additionally adjusted for sibling high risk
status, in order to verify whether transition and non-transition
differed in key variables independent of sibling high risk status.
In order to validate transitions, a comparison was made
between transition and non-transition status with respect to key
baseline variables as well as with respect to changes from baseline
to follow-up. We thus expected that those who would make a
transition to psychotic disorder would display more developmental
impairment and higher levels of psychometric risk indicators at
baseline (as measured with the CAPE, WHOQOL, PAS and
WAIS). Differences in change from baseline to follow-up were
examined in an xtmixed model of a repeated measure, whilst fitting
an interaction between measurement occasion and transition
status. Stratified associations were derived by linear combination
from the model containing the interaction using the Stata margin
command. The population attributable fraction associated with
proxy environmental and genetic exposures was calculated using
Table 2. Differences at baseline as a function of follow-up attrition.
Mean or % SD n F or x2 p
Age at baseline No follow-up 28.1 9.6 374 2.4 0.126
Follow-up 28.9 9.2 1,272




No follow-up 24% 374 37.5 ,0.001
Follow-up 12% 1,272
Urban birth No follow-up 41% 326 8.5 0.004
Follow-up 32% 1,193
Cannabis use No follow-up 39% 369 0.4 0.547
Follow-up 37% 1,272
Early Trauma No follow-up 50% 137 0.2 0.654
Follow-up 52% 1,177
CAPE positive No follow-up 0.21 0.21 325 1.6 0.21
Follow-up 0.20 0.18 1,156
CAPE negative No follow-up 0.50 0.37 325 3.1 0.077
Follow-up 0.54 0.36 1,156
WHOQOL
physical
No follow-up 4.05 0.57 310 8.0 0.005
Follow-up 4.15 0.53 1,174
WHOQOL
mental
No follow-up 3.85 0.55 309 1.0 0.326
Follow-up 3.88 0.52 1,174
WHOQOL
social
No follow-up 3.86 0.76 309 1.2 0.282
Follow-up 3.91 0.65 1,174
WHOQOL
environmental
No follow-up 3.89 0.57 309 26.7 ,0.001
Follow-up 4.06 0.47 1,174
IQ No follow-up 101.0 14.1 342 37.6 ,0.001
Follow-up 106.7 15.7 1,236
PAS premorbid
adjustment
No follow-up 1.20 0.63 347 4.9 0.027
Follow-up 1.11 0.63 1,187
doi:10.1371/journal.pone.0076690.t002
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the cc command in Stata, and defined as the reduction in incidence
that would be observed if the population were entirely unexposed,
compared with its current exposure pattern.
Results
Sample and attrition
At baseline, the risk set consisted of 589 healthy comparison
subjects and 1057 siblings. Baseline demographic characteristics
are shown in table 1. Of these, respectively 462 (men: 44%, mean
age: 34.2 years, sd = 10.6) and 810 (men: 44%, mean age:
30.5 years, sd = 7.9) were seen at follow-up. Attrition was
associated with male sex, urban environment and ethnic minority
status, as well as with lower IQ and small differences in premorbid
adjustment (Table 2). Attrition was not associated with age at
baseline, CAPE positive or negative symptoms, cannabis use,
childhood trauma and WHOQOL-BREF domains (small or non-
significant differences; Table 2).
Transition
Those who made a transition to psychotic disorder were
younger at baseline (transition: 22.9 years, sd = 4.8; non-
transition: 29.0 years, sd = 9.2 years; F = 4.82, p= 0.028). Tran-
sition was not associated with sex (OR=1.4, 95% CI: 0.4–4.7).
The 11 transitions were characterized by higher baseline
psychopathology (CAPE positive and negative domains), poorer
WHO-QOL scores, lower IQ and poorer premorbid adjustment
(Table 3). In addition, transitions also displayed greater increases
in psychopathology from baseline to follow-up (CAPE positive and
CAPE negative) and greater decreases in quality of life, with the
exception of the environmental domain. Transition was not
associated with changes in IQ (Table 3). One of the 11 individuals
had a non-psychotic DSM-IV diagnosis at baseline (300.3
obsessive-compulsive disorder), in the absence of significant
psychotic symptoms at interview.
Environmental and genetic prediction of transition
The majority of high-risk siblings (68%) and healthy comparison
subjects (60%) had been exposed to one or more environmental
risks. The risk of transition in siblings (n = 9 out of 810, 1.1%) was
higher than the risk in healthy comparison subjects (n = 2 out of
462, 0.4%; OR adjusted for age and sex = 2.2, 95% CI: 0.5210.3;
Table 4). All transitions were associated with environmental
exposure, compared to 65% of non-transitions (p = 0.014), with
the greatest effects for childhood trauma (OR adjusted for age, sex
and sibling status = 34.4, 95% CI: 4.42267.4), cannabis use
(OR=4.1, 95% CI: 1.1, 15.4), minority ethnic group (OR=3.8,
95% CI: 1.2, 12.8) and urban birth (OR=3.7, 95% CI: 0.9, 15.4)
(Table 3). The proportion of transitions in the population
attributable to environmental risk (PAF), assuming causality,
ranged from 28% for minority ethnic group, 45% for urban
birth, 57% for cannabis use, 86% for childhood trauma, and 50%
for high-risk sibling status (Table 4). Nine out of 11 transitions
(82%) were exposed to both proxy genetic and environmental risk,
compared to only 43% of non-transitions (p = 0.03; Table 5).
Discussion
In order to assess the importance of environmental and genetic
risk on transition from health to psychotic disorder, a prospective
study of a cohort of individuals with average and high genetic risk
Table 4. Transition as a function of proxy environmental and genetic exposures.
Non-transition Transition Odds ratioadj* 95% CI PAF
#
n % n %
Minority position Majority 1,117 88.5 7 63.6 3.8 1.2212.8 28%
Minority 145 11.5 4 36.4
Urban birth Non-urban 807 68.0 3 32.0 3.7 0.9215.4 45%
Urban 379 37.5 5 62.5
Cannabis use No use 798 63.2 3 27.3 4.1 1.1215.4 57%
Use 464 36.8 8 72.7
Early trauma No 921 78.9 1 11.1 34.4 4.42267.4 86%
Yes 247 21.2 8 88.9
Any exposure No 447 35.4 0 0.0 ‘
Yes 815 64.6 11 100.0
High risk group Comparison subject 460 99.6 2 0.4 2.2 0.5210.3 50%
Sibling 802 98.9 9 1.1
*Odd ratio’s adjusted for age sex and high-risk sibling status.
# PAF = population attributable fraction, or the reduction in incidence that would be observed if the population were entirely.
unexposed, compared with its current exposure pattern.
‘=OR is infinity due to zero denominator.
doi:10.1371/journal.pone.0076690.t004
Table 5. Transition status as a function of exposure to proxy
environmental (E) and/or genetic (G) exposures.
Neither G
nor E G or E G and E
Non-transition n 184 539 539
% 14.6 42.7 42.7
Transition n 0 2 9
% 0.0 18.2 81.8
Pearson chi2 (2) = 7.0 Pr = 0.030.
doi:10.1371/journal.pone.0076690.t005
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was carried out. The findings suggest that the rate of exposure to
any environmental risk in the population is very high, or semi-
ubiquitous, and that transition from health to psychotic disorder is
strongly dependent on such exposure. Thus, all environmental risk
factors were associated with transition to psychotic disorder, with
the greatest effect, in terms of both relative and attributable risk,
for childhood trauma. Exposure to environmental risk did not vary
as a function of genetic high risk status, suggesting absence of
genetic control of environmental exposure, or gene-environment
correlation. In those who made the transition to psychotic
disorder, 82% were exposed to both proxy genetic and environ-
mental risk, compared to only 43% of those who did not
transition. This finding suggests that exposure to both genetic and
environmental risk factors is necessary for transition, which is
compatible with underlying gene-environment interaction. Careful
prospective documentation therefore suggests most transitions can
be attributed to powerful environmental effects operating against
elevated background genetic risk.
Incidence of transition
Johnstone and colleagues followed a cohort of 163 young adults
at average and high genetic risk, of which about 12% made a
transition to psychotic disorder within 2.5 years [7], representing a
yearly transition rate of 4.9% [7]. The yearly transition rate in the
current study was 0.34% for siblings (1.1%/3.3 years of follow-up),
and 0.13% for healthy comparison subjects (0.4%/3.3 years of
follow-up). Differences with the Edinburgh high risk study of
Johnstone and colleagues [32] may be related to the fact that their
‘‘high-risk’’ denoted more familial loading (2 affected relatives),
and that the mean age was younger (21 years). The incidence in
the healthy comparison subjects of the current study (0.13%)
appears high compared to the classic incidence estimate of
schizophrenia (0.02%). However, a direct comparison is not valid
as our outcome included all affective and non-affective psychosis,
was restricted to a young age group and case identification did not
depend on use of health care. Previous work has shown that the
rate of psychosis, thus defined, is up to six times higher than
typical estimates [33].
The binary concept of transition may be difficult to define [9].
However, in the context of the current study, transition was from
health to psychotic disorder, a clear and valid qualitative contrast
that can be assessed reliably in the context of a clinical follow-up.
The comparisons between transition and non-transition add to the
notion of a valid contrast, given pre-transition differences in
premorbid adjustment and cognition, that did not further decline
after onset, conform expectation [34,35]. However, the finding
that cognition does not decline after onset has not been undisputed
[36]. In addition, individuals developing psychotic disorder over
the follow-up period displayed higher non-specific indices of
psychometric risk and maladjustment as measured with the CAPE
and WHOQOL at baseline, conform the model of clinical staging
[37]. Furthermore, transition resulted in substantial increases for
these variables, indicating true clinical change.
Comparison with previous work
[LOOSSER]The results are in line with previous research
showing associations between several environmental risk factors
and development of psychotic symptoms or psychotic disorder
[124], particularly in those at high risk [5]. As ‘‘high-risk’’ in the
current study was defined on the basis of higher than average
genetic risk, rather that psychometric risk as observed in UHR
samples [38] or samples with attenuated psychotic symptoms in
the general population [39], comparison with previous work is
limited. Both Habets and colleagues [40], as well as Welch and
colleagues [41] showed that cannabis use was associated with
differential impact on brain structures in individuals at familial
high risk for schizophrenia, which Habets and colleagues
furthermore did not observe in controls. Similarly, epidemiological
studies have demonstrated that the impact of urbanicity on
schizophrenia risk is greater in those with additional evidence of
elevated genetic risk [21,42,43].
Genetic risk and environment risk: ubiquitous?
Studies focussing on the nature and extent of molecular genetic
risk for schizophrenia have provided ‘‘molecular genetic evidence
for a substantial polygenic component to the risk of schizophrenia
involving thousands of common alleles of very small effect’’ [44].
In other words, molecular genetic variation contributing to risk for
schizophrenia can be considered ubiquitous and distributed.
Interestingly, the current study, being one of the first to examine
multiple environmental risks together, suggests that conceptually
the situation with regard to environmental risks may be similar.
Thus, most individuals in the population were exposed to one or
more of the environmental risks included in this study, and most of
the transitions were attributable to environmental risk factors,
against a background of genetic risk (most of the transitions being
siblings of higher than average genetic risk). Methodologically this
is an important issue, as the impact of a risk factor on a disease
outcome cannot be detected if the entire population is exposed,
unless the population can be separated into those who are
differentially susceptible. Given the very high rate of exposure to
environmental risks, the results suggest that careful follow-up of
samples of differential genetic risk for psychotic disorder may be
necessary to examine the true impact of environmental risk factors.
The nature of the impact of the environmental risks examined
in the current study requires further clarification. First, the
sample was too small to examine to what degree the
environmental risks acted additively or more-than-additively.
Previous work in general populations samples suggest that
relationships may be both additive [45] and more-than-additive
[46,47]. In addition, the focus was on postnatal risk factors,
although pre-natal risks may also play an important role
[48251].
Second, the data are not informative as to when and how the
environmental factors examined impact on development to
increase risk, and whether environmental risks gave rise to
enduring liability early in life, or acted as precipitants in
individuals at higher than average genetic risk. The temporal
focus of the current investigation was on transition from health to
illness, and retrospective examination of environmental impact is
methodologically challenging.
A remarkable finding was the very high relative and attributable
risk associated with childhood trauma. Given the prospective
nature of the investigation, bias associated with a ‘‘search for
meaning’’ cannot explain the results, in agreement with a growing
number of prospective analyses testing the relationship between
childhood adversity on the one hand, and psychosis on the other
[52256]. The results confirm the need to urgently identify the
nature and the mechanism of risk associated with early adversity,
as well the clinical implications thereof [57].
Methodological issues
Strengths of the study include careful prospective assessment
and confirmation of control status by excluding those with a
positive family history. Because of the relatively short follow-up
period, the number of individuals in this study who transitioned to
psychotic disorder was relatively small. Although some results were
statistically conclusive, other analyses, for example risk associated
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with sibling status, were underpowered. As the sample will be seen
again at six-year follow-up, amplification of the sample and more
robust results will be possible, as well as more fine-grained testing
of relationships between genetic and non-genetic risks. Another
issue is selection, as the focus was on transition in siblings and
healthy comparison subjects who had lived through a substantial
period of risk. It cannot be excluded that the mix of risk factors
impacting on transition varies as a function of age-at-onset, thus
the results cannot necessarily be generalised to transitions from
health to illness at all ages.
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